SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Angiology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Pistevos, A.
Right arrow Articles by Darsinos, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pistevos, A.
Right arrow Articles by Darsinos, I.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Progress of Coronary Artery Disease: Compliance to Therapy

A. Pistevos

"Alexandra" Hospital, Athens, Greece

J. Georgiou

"Alexandra" Hospital, Athens, Greece

I. Darsinos

"Alexandra" Hospital, Athens, Greece

From a sample of 1,824 patients with coronary artery disease (CAD) at the time of their interview, 827 males (M) and 251 females (F), had at least one distinct recurrence of their disease—some type of angina (A) or myocardial infarction (MI). In these patients, the age and type of CAD at the first and second manifes tations (MSs) were noted, together with the patient's compliance to pre scribed therapy. The first MF of CAD in Ms was A in 61% at the age of 59.4±10.15 years and MI in 39% at a significantly younger age (54.4±10.54 years, p < 0.001). In Ms with A, the second MF was again A in 39% at the age of 61.4±10.14 years and MI in 61% at 62.1±10.2 years. In Ms with MI, the second MF was A in 85% at 56.5±10.52 years and MI in 15% at 59.2±12.0 years. No statis tical difference was found between patients with good or poor compli ance to therapy in connection with the time of the second MF as A or MI. A significantly lower percentage of MI after A, as the first MF, was found in patients with good compli ance (55%) than in patients with poor compliance (69%, p < 0.01). In Fs the first MF was A in 88% at 61.6±9.82 years and MI in 12% at 58.1±9.1 years (p < 0.05). The second MF for all F patients was MI in 48% at 65.4±10.02 years, compared with A in 52% at the age of 64.5±9.78 years. Conclusions: In Ms a rather quick ({cong}2.5 years) progression of CAD is expected after its initial MF mainly as A ({cong} 61 %), and in these, MI as the second MF is more common in pa tients with poor compliance to ther apy. In Fs there is a delayed first MF mainly as A ({cong}90%) and a delayed second MF as A and MI in equal pro portion.

Angiology, Vol. 40, No. 7, 666-670 (1989)
DOI: 10.1177/000331978904000709


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement